A malaria treatment designed for babies and very young children has been approved for use for the first time, and is expected to be rolled out in African countries within weeks. The treatment has been touted as an advance against the deadly disease that kills hundreds of thousands of people each year, nearly all in Africa. Martin Fitchet is the CEO of Medicines for Malaria Venture, one of the organisations involved in developing the drug.
